Clinical review demonstrates transformative diagnostic and therapeutic developments in cardiac transthyretin amyloidosis, highlighting improved disease recognition and clinical management.
Introduction In recent decades, significant advances have led to a complete reformulation of clinical and epidemiological concepts about cardiac transthyretin (ATTR) amyloidosis, summarized in . […]
No takes yet. Share an insight, caveat, or question.
Simões et al. (2023) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: